This groundbreaking observation is presented as Late Breaking Research at the AACR Annual Meeting in Chicago on Tuesday by Dr Sudipto Chakrabortty.
Read More »Exosome Dx and Takeda Partner to Develop RNA Sequencing Platform for Biomarkers
Exosome Diagnostics, Inc., the world’s only provider of an exosome liquid biopsy platform to monitor disease biomarkers in patient blood, with the goal of reducing or eliminating the need for tissue biopsies, has entered into a collaboration with Takeda Pharmaceuticals ...
Read More »Exosome Diagnostics and the Addario Lung Cancer Medical Institute (ALCMI) to Collaborate on Development of Liquid Biopsy Cancer Diagnostics
Clinical testing underway utilizing matched samples from ALCMI’s Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Trial Collaboration will support validation for Exosome Diagnostics’ ALK and T790M plasma-based diagnostics planned to launch in 2015 Novel biofluid-based diagnostics offer the potential to ...
Read More »